| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/13/2010 | US20100120671 Novel antimicrobial agents |
| 05/13/2010 | US20100120670 Cyclised alpha-conotoxin peptides |
| 05/13/2010 | US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| 05/13/2010 | US20100120668 Method of treatment of photodermatoses |
| 05/13/2010 | US20100120667 Composition for preventing and/or treating peptic ulcers |
| 05/13/2010 | US20100120666 Methods of treatment using glycopegylated g-csf |
| 05/13/2010 | US20100120665 Treatment of diseases characterized by inflammation |
| 05/13/2010 | US20100120664 Modified coagulation factors with prolonged in vivo half-life |
| 05/13/2010 | US20100120663 Method for inducing thrombopoiesis |
| 05/13/2010 | US20100120662 Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 05/13/2010 | US20100120661 Heterocyclic boronic acid compounds |
| 05/13/2010 | US20100120660 Highly concentrated insulin solutions and compositions |
| 05/13/2010 | US20100120652 Treatment of bed mite and bed bug infestations |
| 05/13/2010 | US20100120151 enables embryogenic tissue to be detected in vitro thus allows for early discading of non-embryonic tissue; antioxidant; inhibition or retardation of apoptotic processes; tablet or cream form as an antiaging agent; used in generating male sterile plants |
| 05/13/2010 | US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 05/13/2010 | US20100120056 Diagnosis and monitoring of diseases |
| 05/13/2010 | US20100120029 Mutagenesis of aspergillus fungi and genes essential for growth |
| 05/13/2010 | US20100119617 Multi-nutrient milk fortifier |
| 05/13/2010 | US20100119610 Packaged pegylated gold nanoparticles |
| 05/13/2010 | US20100119604 Solid drug formulation and device for storage and controlled delivery thereof |
| 05/13/2010 | US20100119593 Liposome and method for producing the same |
| 05/13/2010 | US20100119588 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 05/13/2010 | US20100119580 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 05/13/2010 | US20100119574 Recombinant Gelatins |
| 05/13/2010 | US20100119573 Endothelium mimicking nanomatrix |
| 05/13/2010 | US20100119568 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 05/13/2010 | US20100119563 Solid fibrinogen preparation |
| 05/13/2010 | US20100119561 Compositions Having a Performance Indicator |
| 05/13/2010 | US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2010 | US20100119543 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/13/2010 | US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus |
| 05/13/2010 | US20100119525 Method for extending longevity using npc1l1 antagonists |
| 05/13/2010 | US20100119523 Vascular endothelial cell growth factor antagonists |
| 05/13/2010 | US20100119522 Combination therapy for the treatment of ocular neovascular disorders |
| 05/13/2010 | US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors |
| 05/13/2010 | US20100119519 Ophthalmic drug delivery system and method |
| 05/13/2010 | US20100119518 Target for breast cancer therapy and/or diagnosis |
| 05/13/2010 | US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/13/2010 | US20100119513 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 05/13/2010 | US20100119512 Methods of diagnosing, treating, and preventing increased vascular permeability |
| 05/13/2010 | US20100119508 Phenylacetic acid inhibitors of cyclooxygenase |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/13/2010 | US20100119505 Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation |
| 05/13/2010 | US20100119502 Therapy regimens, dosing regimens and stable medicaments for the treatment of pompe disease |
| 05/13/2010 | US20100119501 Method of delivering a protein into a cell |
| 05/13/2010 | US20100119500 Method for preparing silica compositions, silica compositions and uses thereof |
| 05/13/2010 | US20100119499 Stilbene-based compositions and methods of use therefor |
| 05/13/2010 | US20100119498 Dietary supplement for promoting wellness and weight loss and methods of administering the same |
| 05/13/2010 | US20100119494 Methods and compositions related to modulating the extracellular stem cell environment |
| 05/13/2010 | US20100119491 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 05/13/2010 | US20100119489 Stimulation of Pancreatic Beta Cell Proliferation |
| 05/13/2010 | US20100119484 Derivatisation of biological molecules |
| 05/13/2010 | US20100119483 Peptide viral entry inhibitors |
| 05/13/2010 | US20100119482 Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase |
| 05/13/2010 | US20100119481 5,6-dihydro-1h-pyridin-2-one compounds |
| 05/13/2010 | US20100119480 Methods for treating multiple sclerosis using antisense oligonucleotides |
| 05/13/2010 | US20100119479 Therapeutic antiviral peptides |
| 05/13/2010 | US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
| 05/13/2010 | US20100119477 Psm peptides as vaccine targets against methicillin-resistant staphylococcus |
| 05/13/2010 | US20100119476 Selection of peptides specific for human blood outgrowth endothelial cells |
| 05/13/2010 | US20100119475 Novel inhibitors of glutaminyl cyclase |
| 05/13/2010 | US20100119474 Chronic obstructive pulmonary disease susceptibility and related compositions and methods |
| 05/13/2010 | US20100119453 Methods of enhancing functioning of the large intestine |
| 05/13/2010 | US20100119451 Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| 05/13/2010 | US20100119450 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer's amyloid-beta peptide |
| 05/13/2010 | US20100119446 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/13/2010 | US20100119445 Plexin d1 as a target for tumor diagnosis and therapy |
| 05/12/2010 | EP2184607A1 Immune response assessment method |
| 05/12/2010 | EP2184358A2 Canine interleukin 18 and remedies for canine immunological diseases |
| 05/12/2010 | EP2184297A1 HLA-G polypeptides and pharmaceutical uses thereof |
| 05/12/2010 | EP2184296A1 Fibroblast growth factor (fgf23) and methods for use |
| 05/12/2010 | EP2184292A1 Anti-Apoptotic Fusion Proteins |
| 05/12/2010 | EP2184291A1 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 05/12/2010 | EP2184070A1 HLA-G proteins and pharmaceutical uses thereof |
| 05/12/2010 | EP2183368A2 Promoterless cassettes for expression of alphavirus structural proteins |
| 05/12/2010 | EP2183362A2 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 05/12/2010 | EP2183275A1 Igf-1r binding polypeptides and their use |
| 05/12/2010 | EP2183273A1 Cyclic depsipeptides |
| 05/12/2010 | EP2183270A1 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 05/12/2010 | EP2183269A2 Method for purifying the factor viii and the von willebrand factor |
| 05/12/2010 | EP2183028A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 05/12/2010 | EP2182977A2 Compositions for the treatment of stroke or cerebrovascular accidents with an endothelin b receptor agonist |
| 05/12/2010 | EP2182975A1 Novel inhibitor of angiogenesis |
| 05/12/2010 | EP2182972A2 Peptide sequences and compositions |
| 05/12/2010 | EP2182970A1 A memory influencing protein |
| 05/12/2010 | EP2182943A2 Methods and compositions for treating fibrosis related disorders using il-17 antagonists |
| 05/12/2010 | EP2182888A2 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 05/12/2010 | EP1711187B1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/12/2010 | EP1613340B1 Treatment of aspergillus infections with thymosin alpha 1 |
| 05/12/2010 | EP1578772B1 Cytokines and cytokine receptors with reduced immunogenicity |
| 05/12/2010 | EP1436397B1 Hepatitis c virus vaccine |
| 05/12/2010 | CN1985987B Medicine composition of glycyrrhizic acid or its salt and reduced glutathione |
| 05/12/2010 | CN1981887B Therapeutic use of growth factor, and delivery device, especially for the treatment of intima hyperplasia |
| 05/12/2010 | CN1966683B Recombinant adenovirus for expression of novel tumour suppressor gene p53 |
| 05/12/2010 | CN1962690B Oxya chinensis(Thunberg) imago antibacterial protein preparation method |
| 05/12/2010 | CN1944463B Fusion protein with alpha-interferon activity and its coded gene and use |
| 05/12/2010 | CN1927232B Ganoderma lucidum spore powder and process for preparing capsule thereof |
| 05/12/2010 | CN1911447B Transferrin-polyethylene glycol medicine molecular compound, and used of medicine prepared by the same |
| 05/12/2010 | CN1872875B Anti-viral protein of ash tree flower, method of extraction, and application |
| 05/12/2010 | CN1853609B Skin-care effectiveness applied by acid fiber mother cell growth factor (FGF-1) |